Suchergebnisse - "Immunologic Factors"

PubPharm (1.530)

1

Initial rituximab monotherapy for adult indiopathic nephrotic syndrome with minimal change lesion pattern

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2024

von Xu, R. | Hu, H. | Xu, H. | +7

2

Synergistic effects of Boswellia serrata and Acmella oleracea extract combination for treating neuropathic pain in a preclinical model of spared nerve injury

enthalten in: Phytotherapy research : PTR | 2024

von Boccella, S. | Mattia, C. | Perrone, M. | +5

3

Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis : a cohort study

enthalten in: Annals of the rheumatic diseases | 2024

von Schiff, A. | Wang, X. | Patel, N. | +13

UpdateOf: medRxiv. 2023 Oct 09;:. - PMID 37873462

4

Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy

enthalten in: Journal of neurology | 2024

von Maillart, E. | Todesco, E. | Assoumou, L. | +8

5

Infratentorial posterior reversible encephalopathy syndrome in INFβ1a-treated multiple sclerosis patient

enthalten in: Journal of neurology | 2024

von Cutillo, G. | Rubin, M. | d'Amore, G. | +6

6

Potential factors associated with a long-term duration of B-cell depletion after using rituximab in patients with nephrotic syndrome

enthalten in: Pediatric nephrology (Berlin, Germany) | 2024

von Xue, C. | Dai, B.

7

Serum sickness in a multiple sclerosis patient treated with ocrelizumab

enthalten in: Journal of neurology | 2024

von Mantero, V. | Cordano, C. | Balgera, R. | +3

8

Long-term remission with rituximab therapy in a five-year-old patient with pemphigus vulgaris

enthalten in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG | 2024

von Erdoğan, B. | Meral, E. | Topkarci, Z. | +2

9

Author's Reply : "Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?"

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2024

von Sousa, P. | Magro, F.

10

Half-dose ocrelizumab in selected patients with relapsing-remitting multiple sclerosis

enthalten in: Acta neurologica Belgica | 2024

von Algahtani, H. | Shirah, B. | Alqahtani, A. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[153]